Final answer:
Short-acting anti-anxiety benzodiazepine agents include Lorazepam, Diazepam, and Clonazepam, making the correct answer d) All of the above.
Step-by-step explanation:
The subject of this question is Medicine. Short-acting anti-anxiety benzodiazepine agents include Lorazepam, Diazepam, and Clonazepam, therefore the correct answer is d) All of the above.
Short-acting benzodiazepines are a class of medications commonly prescribed for the short-term management of anxiety, insomnia, and certain other conditions. These medications work by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that has inhibitory effects in the brain. Here are some examples of short-acting benzodiazepines:
Alprazolam (Xanax):
Alprazolam is commonly prescribed for the treatment of generalized anxiety disorder (GAD) and panic disorder.
It has a relatively short half-life, meaning it is quickly metabolized in the body.
Lorazepam (Ativan):
Lorazepam is used to treat anxiety disorders, as well as for short-term relief of anxiety symptoms.
It is also employed in the treatment of certain seizure disorders.
Lorazepam has a relatively short duration of action.
Triazolam (Halcion):
Triazolam is primarily prescribed for the short-term treatment of insomnia.
It has a rapid onset of action and a short duration of effect.
Midazolam:
Midazolam is often used for sedation before medical procedures or surgery.
It has a quick onset of action and a relatively short duration.
It's important to note that while short-acting benzodiazepines can be effective for managing symptoms in the short term, they are associated with the risk of dependence and withdrawal symptoms if used for extended periods. Therefore, these medications are generally prescribed for brief durations, and healthcare providers carefully assess the potential risks and benefits when considering benzodiazepine therapy.
Patients should use these medications as directed by their healthcare provider and should not abruptly stop taking them without proper medical guidance, as withdrawal symptoms can occur. Individuals need to discuss any concerns or questions about benzodiazepine use with their healthcare provider.